Brief: PepGen Announces Highest Mean Splicing Correction Reported In DM1 Patients

Sept 24 (Reuters) - PepGen Inc PEPG.O:

PEPGEN ANNOUNCES HIGHEST MEAN SPLICING CORRECTION REPORTED IN DM1 PATIENTS

PEPGEN: 53.7% MEAN SPLICING CORRECTION OBSERVED FOLLOWING SINGLE 15 MG/KG DOSE OF PGN-EDODM1, WITH ALL PATIENTS SHOWING IMPROVEMENT IN SPLICING

PEPGEN: PGN-EDODM1 WAS GENERALLY WELL-TOLERATED AT 15 MG/KG, WITH DRUG-RELATED ADVERSE EVENTS MILD OR MODERATE IN SEVERITY

Source text: ID:nBw4pPf7Ha

Further company coverage: PEPG.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on PepGen

See all news